Is there an indication for high-dose chemotherapy (HDCT) with autologous peripheral blood stem cell support (PBSCT) in the treatment of patients with bone and soft-tissue sarcomas?

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 9079-9079
Author(s):  
B. Kasper ◽  
T. Lehnert ◽  
L. Bernd ◽  
G. Egerer
2010 ◽  
Vol 21 (7) ◽  
pp. 1482-1485 ◽  
Author(s):  
L. Castagna ◽  
S. Bramanti ◽  
A. Levis ◽  
M.G. Michieli ◽  
A. Anastasia ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document